Abstract: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an innovation in liver surgery in recent years. It provides opportunities of surgery for those with inadequate remnant liver volume by rapidly remnant liver hypertrophy. Comparing with conventional two stage hepatectomy (TSH), such as portal vein embolization, transcatheter arterial chemoembolization and hepatic artery ligation, ALPPS has advantages of fastened future liver remnant hypertrophy, shortened waiting time for the second stage of surgery and higher resection rate. But as for long-term curative effect, no strong evidence shows ALPPS is better than TSH.